PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 99 |
| PubMedID- 20349347 | The cardiovascular disease associated with the metabolic syndrome and with diabetes mellitus comprises vascular and myocardial abnormalities. |
| PubMedID- 21397002 | metabolic syndrome increases the risk of developing cardiovascular diseases, hypertension and type-2 diabetes, among other diseases. |
| PubMedID- 23497138 | Subjects with evfa ≥100 cm2 were significantly more likely to have the metabolic syndrome and history of cardiovascular diseases, compared to those with evfa <100 cm2 (p<0.001, p=0.028, respectively). |
| PubMedID- 24844874 | Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn). |
| PubMedID- 25541285 | The insulin-like growth factor i system: physiological and pathophysiological implication in cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 25725623 | These lipid abnormalities are known to promote cardiovascular disease in individuals with the metabolic syndrome [34]. |
| PubMedID- 22205060 | The worldwide obesity epidemic has brought to the author's attention the cardiometabolic risk factors and cardiovascular disease associated with the metabolic syndrome. |
| PubMedID- 24889279 | Smoking, diabetes, metabolic syndrome, history of cardiovascular disease, increased waist circumference, and elevated pre-treatment ldl-c level were all associated with not reaching ldl-c goals. |
| PubMedID- 21409896 | Background: the metabolic syndrome is a cluster of various cardiovascular disease risk factors: diabetes and pre-diabetes, abdominal obesity, hyperlipidaemia and high blood pressure. |
| PubMedID- 22760893 | Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases. |
| PubMedID- 19781706 | There is ample epidemiological evidence linking obesity, and the related ‘metabolic syndrome’, with vascular disease [1]. |
| PubMedID- 22417460 | High sensitivity c-reactive protein (hs-crp), a marker of systemic inflammation and a predictor of type 2 diabetes and cardiovascular disease, is associated with the metabolic syndrome and its separate components. |
| PubMedID- 23936649 | The association of metabolic syndrome with cardiovascular disease was already observed more than 40 years ago [187]. |
| PubMedID- 24393433 | Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd). |
| PubMedID- 21318102 | Increasing plasma apn or enhancing apn signal transduction may be an ideal strategy to prevent and treat the cardiovascular diseases associated with metabolic syndrome. |
| PubMedID- 25957218 | Sustained release nitrite therapy results in myocardial protection in a porcine model of metabolic syndrome with peripheral vascular disease. |
| PubMedID- 19958158 | Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress. |
| PubMedID- 21808142 | Cd36 deficiency is related to phenotypic expression of the metabolic syndrome, frequently associated with atherosclerotic cardiovascular diseases resulting in raised levels of glucose thereby contributing to type 2 diabetes (t2dm). |
| PubMedID- 26525819 | Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome. |
| PubMedID- 20508159 | The hypothesis that rimonabant has protective effects against vascular disease associated with the metabolic syndrome was tested using jcr:la-cp rats. |
| PubMedID- 22682107 | Background: to evaluate the importance of oral glucose tolerance test (ogtt) in predicting diabetes and cardiovascular disease in patients with and without metabolic syndrome from a population treated in a primary care unit. |
| PubMedID- 22916265 | The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity. |
| PubMedID- 23323622 | Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome. |
| PubMedID- 23869305 | [39404142] because of the increased cardiovascular disease (cvd) risk associated with the metabolic syndrome and extensive clinical trial evidence documenting reduction of cvd risk with statin treatment, all patients with the metabolic syndrome should be evaluated as candidates for statin treatment as part of a multidisciplinary approach to reduce cvd risk. |
| PubMedID- 20823276 | Aims: the adipokine visfatin, produced during obesity, has been reported to participate in the development of cardiovascular disease associated with metabolic syndrome. |
| PubMedID- 23285034 | It is, however, inconsistent with several other observational studies [4]; [41]; [42], including a recent study by thomas et al who found an optimal vitamin d level to lower all-cause and cardiovascular disease mortality in patients with the metabolic syndrome [43]. |
| PubMedID- 23334870 | This study assesses the feasibility and efficacy of a multifactorial approach for primary prevention of cardiovascular disease risk assessment in patients with metabolic syndrome in the daily clinical practice setting. |
| PubMedID- 21122628 | Background: metabolic syndrome is associated with increased cardiovascular disease (cvd) risk, a risk that is significantly increased when accompanied by elevated low-density lipoprotein cholesterol (ldl-c). |
| PubMedID- 24926685 | Nafld is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. |
| PubMedID- 23199128 | In this review, we first describe the population trend in the degree of obesity as measured by the body mass index (bmi), and review prospective cohort studies that reported associations of obesity measures and metabolic syndrome (mets) with cardiovascular diseases (cvd) in japanese. |
| PubMedID- 21679922 | Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome. |
| PubMedID- 23961478 | For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors. |
| PubMedID- 21123363 | The metabolic syndrome is associated with elevated peripheral vascular disease risk, characterized by mismatched blood flow delivery/distribution and local metabolism. |
| PubMedID- 24320034 | The metabolic syndrome (mets), a cluster of risk factors for cardiovascular disease and type 2 diabetes, has become an important public health problem. |
| PubMedID- 20553596 | Given the prognostic significance of the metabolic syndrome in patients with vascular disease, we evaluated the association of vfa, sfa and lfp with metabolic syndrome in a high-risk vascular cohort. |
| PubMedID- 23433013 | The researchers suggested increased arterial stiffness as a risk factor for cardiovascular disease in subjects with metabolic syndrome. |
| PubMedID- 20609696 | In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome. |
| PubMedID- 25228949 | Furthermore, metabolic syndrome is associated with vascular diseases including ph. |
| PubMedID- 23056106 | Hrr and hs-crp, for predicting the risk of cardiovascular diseases in individuals with and without metabolic syndrome who attended the isfahan cohort study. |
| PubMedID- 21269524 | For example, in a cohort study of 2,815 patients [9], the risk of cardiovascular disease (cvd) mortality associated with the metabolic syndrome (hr: 2.53; 95% ci: 1.74 to 3.67) was similar to the risk associated with impaired fasting glucose (hr: 2.87; 95% ci: 1.96 to 4.20). |
| PubMedID- 19720470 | Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk. |
| PubMedID- 24453423 | Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us [27–29], ethnicity did not impact the il-6-endothelial activation relationship in the present investigation. |
| PubMedID- 24282924 | metabolic syndrome is a cluster of risk factors for cardiovascular disease that affects an estimated 50 million americans. |
| PubMedID- 25633268 | Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd). |
| PubMedID- 21130454 | Given the frequent concordance of metabolic diseases including diabetes, obesity, and metabolic syndrome with cardiovascular diseases associated with hyperlipidemia, it is important to understand the potential metabolic risks and benefits of therapies with distinct statins. |
| PubMedID- 20235745 | Background: metabolic syndrome is a combination of risk factors for cardiovascular disease and diabetes, it has been reported to be increased in human immunodeficiency virus (hiv)-infected individuals. |
| PubMedID- 23524050 | The development of gestational diabetes and even milder forms of dysglycemia during pregnancy represents a maternal phenotype at increased subsequent risk for developing type 2 diabetes mellitus, metabolic syndrome, and, with time, overt cardiovascular disease. |
| PubMedID- 23300705 | These risks include obesity and metabolic syndrome associated with cardiovascular disease. |
| PubMedID- 22359422 | The metabolic syndrome among patients with cardiovascular disease in accra, ghana. |
| PubMedID- 23306779 | Moreover, vascular insulin resistance negatively impacts vascular health by affecting blood pressure regulation, vessel wall inflammation and atherogenesis thereby contributing to the burden of vascular disease seen with diabetes and metabolic syndrome. |
Page: 1 2